⏳ Fetching live dividend data...
Home › Calculator › SBFM Dividend Calculator 2026
Sunshine Biopharma, Inc. · NASDAQ
Price: $2.39 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in SBFM → $163273388068.05M in 10 years · $13,590,255,949,817,674.00/month
Sunshine Biopharma, Inc., a pharmaceutical and nutritional supplement company, focuses on the research and development of anticancer drugs. The company is developing Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin to treat leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, liver, and other forms of cancers, as well as kills multidrug resistant cancer cells, including pancreatic cancer, breast cancer, small-cell lung cancer, and uterine sarcoma cells; and SBFM-PL4, an anti-coronavirus treatment compound. It also offers Essential 9, a nutritional supplement tablet; and Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name, as well as develops and markets other science-based nutritional supplements. The company has a license agreement with the University of Georgia to advance the development of its anti-coronavirus lead compound, SBFM-PL4. Sunshine Biopharma, Inc. is headquartered in Pointe-Claire, Canada.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open SBFM position with:
Real after-tax yield depends on where you live and how you hold SBFM.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 83.68% | 80.88% | $8,368 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 71.13% | 68.33% | $7,113 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 66.94% | 64.14% | $6,694 / yr |
| 🇬🇧 UK ISA | 0% | 83.68% | 80.88% | $8,368 / yr |
| 🇬🇧 UK Taxable | 8.75% | 76.36% | 73.56% | $7,636 / yr |
| 🇨🇦 TFSA | 0% | 83.68% | 80.88% | $8,368 / yr |
| 🇨🇦 CA Taxable | 25% | 62.76% | 59.96% | $6,276 / yr |
| 🇦🇺 Super (pension) | 15% | 71.13% | 68.33% | $7,113 / yr |
| 🇦🇺 AU Taxable | 30% | 58.58% | 55.78% | $5,858 / yr |
| 🇩🇪 DE Taxable | 26.375% | 61.61% | 58.81% | $6,161 / yr |
| 🇫🇷 FR Taxable | 30% | 58.58% | 55.78% | $5,858 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
SBFM pays quarterly — 4 times per year. Next ex-div: TBD.
How SBFM compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for SBFM sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-04-14 | 100,000 | — | — | ||
| Buy | 2024-03-04 | 100,000 | $0.10 | $10.0K | ||
| Buy | 2024-02-08 | 20,000 | $0.10 | $2.0K | ||
| Buy | 2022-11-30 | 30,000 | $0.76 | $22.9K | ||
| Buy | 2022-06-03 | 25,000 | $1.22 | $30.5K | ||
| D-Return | 2022-02-18 | 990,000 | $0.10 | $99.0K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the SBFM dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →